The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for CardioCommand sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights CardioCommand Inc, United States Revenue

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

CardioCommand is a medical device company that develops patient monitoring devices. It offers products such as transesophageal atrial pacing systems, transesophageal cardiac stimulators, esophageal bipolar pacing and recording catheters, amplification and signal processing modules, patient lead wires, EP connect cables, interface cable, pin connectors, and esophageal octapolar recording catheters. The company provides turnkey medical device contract manufacturing services, systems integration, materials management, printed circuit board assembling, distribution, and devices repair and warranty services. CardioCommand’s products are used in the treatment of cardiac condition disorders. The company caters to medical and veterinary device markets. CardioCommand is headquartered in Tampa, Florida, the US.

The key metrics of CardioCommand related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As CardioCommand is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as CardioCommand.

For a detailed understanding of the performance of CardioCommand, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.